The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Share News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,188.00
Bid: 4,185.00
Ask: 4,187.00
Change: 8.00 (0.19%)
Spread: 2.00 (0.048%)
Open: 4,164.00
High: 4,188.00
Low: 4,163.00
Prev. Close: 4,180.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Barry Callebaut sticks to sales growth target after solid full year

Wed, 06th Nov 2019 06:26

(Recasts, adds fresh CEO quote, updates share price)

By Silke Koltrowitz

ZURICH, Nov 6 (Reuters) - Barry Callebaut, which
makes chocolate and cocoa products for firms like Nestle
and Unilever, stuck to a sales volume growth
target of 4-6% over the next three years, counting on new
outsourcing deals to fuel growth.

Although global chocolate confectionery consumption is only
growing slowly, Barry Callebaut said its focus on outsourcing
contracts and emerging markets allow it to outperform the
market. A weakness in its business with chefs and artisans would
quickly be fixed, it added.

"Our business is extremely predictable in the medium term,
but there is quite a bit of variation from quarter to quarter,"
Chief Executive Antoine de Saint-Affrique told reporters on
Wednesday after volume growth slowed in the final quarter of the
group's fiscal year from the previous quarter.

This was partly due to scant development in its gourmet and
specialities business with pastry chefs and restaurants -
normally one of its growth drivers - but De Saint-Affrique said
this would be fixed in the second half of the current fiscal
year.

"We didn't renew two contracts that were not on the right
level of profitability and were too slow in renewing and
broadening our customer base," he said, adding he was confident
of returning the unit to mid- to high-single digit growth.

Barry Callebaut shares, which have risen 36% so far this
year, were down 3.6% at 1033 GMT partly due to the slowdown in
the final quarter.

Vontobel analyst Jean-Philippe Bertschy said the share price
had also risen so much that it may be hard to sustain the
current valuation even with the upbeat outlook.

De Saint-Affrique said the Zurich-based company, more than
50% in the hands of the billionaire Jacobs family, was also
working on a pipeline of outsourcing opportunities and could do
bolt-on acquisitions to boost business.

Overall sales volumes grew 5.1% to 2.14 million tonnes in
the 12 months to Aug. 31., while net profit rose 6.9% in local
currencies to 368.7 million Swiss francs ($371 million), the
maker of berry-flavoured "ruby" chocolate said in a statement,
proposing an 8% higher dividend of 26 francs per share.

Kepler Cheuvreux analyst Jon Cox said this was "a solid set
of figures with excellent free cash flow and a dividend ahead of
expectations".

($1 = 0.9927 Swiss francs)
(Reporting by Silke Koltrowitz; Editing by Michael Shields,
Alexander Smith and Emelia Sithole-Matarise)

More News
14 Feb 2024 09:40

LONDON BROKER RATINGS: Panmure likes Nichols; Jefferies cuts Bytes

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 09:13

Deutsche Bank sees more upside at Unilever after strong annual results

(Sharecast News) - Deutsche Bank has kept a 'buy' rating for consumer products group Unilever, saying that while risks remain there is still earnings growth potential within the group after a solid 2023 performance.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:42

TOP NEWS: Unilever sets new EUR1.5 billion buyback despite profit fall

(Alliance News) - Unilever PLC on Thursday said it plans a further EUR1.5 billion share buyback during 2024, maintaining the same pace as in 2022 and 2023, even as it reported a decline in annual profit.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
8 Feb 2024 07:01

Unilever returns to volume growth; Unveils €1.75bn buyback

(Sharecast News) - Consumer goods giant Unilever announced a €1.5bn share buyback as it reported a return to volume growth in the final quarter of 2023, although the result was described as "disappointing" by its chief executive.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
31 Jan 2024 18:15

TRADING UPDATES: Creo unveils product in APAC; Unilever hires director

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
28 Jan 2024 20:25

Sunday share tips: Unilever, Tertre Rouge

(Sharecast News) - The Sunday Times's Lucy Tobin tipped shares of Unilever to her readers, arguing that the shares were cheap.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.